MORGAN STANLEY - VISTAGEN THERAPEUTICS INC ownership

VISTAGEN THERAPEUTICS INC's ticker is VTGN and the CUSIP is 92840H202. A total of 117 filers reported holding VISTAGEN THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 1.91 and the average weighting 0.1%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of VISTAGEN THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$22,838
-11.1%
183,153
-26.6%
0.00%
Q4 2022$25,687
+7.0%
249,386
+61.0%
0.00%
Q3 2022$24,000
-78.9%
154,879
+19.2%
0.00%
Q2 2022$114,000
-87.3%
129,913
-82.1%
0.00%
Q1 2022$899,000
+34.4%
725,276
+111.2%
0.00%
Q4 2021$669,000
+371.1%
343,389
+561.3%
0.00%
Q3 2021$142,000
-78.5%
51,930
-75.2%
0.00%
Q2 2021$660,000
-50.9%
209,513
-66.8%
0.00%
Q1 2021$1,345,000
+5504.2%
631,566
+4934.8%
0.00%
Q4 2020$24,000
+166.7%
12,5440.0%0.00%
Q3 2020$9,000
+28.6%
12,5440.0%0.00%
Q2 2020$7,000
+16.7%
12,5440.0%0.00%
Q1 2020$6,000
-33.3%
12,5440.0%0.00%
Q4 2019$9,000
-30.8%
12,544
-0.1%
0.00%
Q3 2019$13,000
+44.4%
12,559
-0.5%
0.00%
Q2 2019$9,000
-43.8%
12,622
+0.6%
0.00%
Q1 2019$16,00012,544
+2712.6%
0.00%
Q4 2017$04460.00%
Other shareholders
VISTAGEN THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
ACUTA CAPITAL PARTNERS, LLC 11,728,033$36,943,00014.76%
VR Adviser, LLC 16,047,286$50,549,0006.13%
COMMODORE CAPITAL LP 3,331,315$10,494,0003.66%
Ghost Tree Capital, LLC 2,000,000$6,300,0001.73%
EPIQ PARTNERS, LLC 932,956$2,939,0001.47%
SPHERA FUNDS MANAGEMENT LTD. 4,080,673$12,854,0000.87%
SILVERARC CAPITAL MANAGEMENT, LLC 615,547$1,939,0000.86%
HighVista Strategies LLC 308,096$971,0000.69%
NEA Management Company, LLC 16,302,596$51,353,0000.67%
Nicholas Investment Partners, LP 2,753,880$8,675,0000.54%
View complete list of VISTAGEN THERAPEUTICS INC shareholders